Bone Morphogenetic Protein 10 (BMP10) (N-Term) Peptide
Quick Overview for Bone Morphogenetic Protein 10 (BMP10) (N-Term) Peptide (ABIN973838)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- KFATDRTSMP SANIIRSFKN EDLFSQPVSF NGIRKYPLLF NVSIPHHEEV
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Bmp10 Antibody(ARP47031_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BMP10 (Bone Morphogenetic Protein 10 (BMP10))
-
Background
-
Bmp10 is required for maintaining the proliferative activity of embryonic cardiomyocytes by preventing premature activation of the negative cell cycle regulator CDKN1C/p57KIP and maintaining the required expression levels of cardiogenic factors such as MEF2C and NKX2-5. Bmp10 acts as a ligand for ACVRL1/ALK1, BMPR1A/ALK3 and BMPR1B/ALK6, leading to activation of SMAD1, SMAD5 and SMAD8 transcription factors. Bmp10 inhibits endothelial cell migration and growth.
Alias Symbols: Bmp10
Protein Size: 421 -
Molecular Weight
- 48 kDa
-
Gene ID
- 500245
-
NCBI Accession
- NM_001031824, NP_001026994
-
UniProt
- Q4AEG6
Target
-